Michele D. Bronson

Health Technology

Consumer Services

Profile

Michele D.
Bronson worked as a Director of Oncology Development at Chiron Corp.
and as a Vice President of Regulatory & Quality at both Labrys Biologics, Inc. and Medivation LLC (California).
She also served as the Chief Development Officer at Nuvation Bio Operating Co., Inc. Bronson holds a doctorate degree from The University of Texas at Austin.

Former positions of Michele D. Bronson

Companies	Position	End
Nuvation Bio Operating Co., Inc. Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY.	Corporate Officer/Principal	-
Chiron Corp. Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA.	Corporate Officer/Principal	-
Labrys Biologics, Inc. Labrys Biologics, Inc. BiotechnologyHealth Technology Labrys Biologics, Inc. provides biotechnology services. It is a venture-financed development stage biotechnology company, which focuses on treatments for chronic migraine. The company was founded by Corey S. Goodman in 2012 and is headquartered in San Francisco, CA.	Corporate Officer/Principal	-
MEDIVATION INC	General Counsel	-

See the detail of Michele D. Bronson's experience

Training of Michele D. Bronson

The University of Texas at Austin

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies